Michelle Eggers

Michelle Eggers has a solid background in preclinical study management and toxicology. Michelle currently holds the position of Senior Director of Preclinical Study Management at Scribe Therapeutics. Before that, they worked at Astellas Gene Therapies, where they held various roles including Director of Nonclinical Study Management, Associate Director of Pharmacology/Toxicology, Senior Manager of Pharmacology/Toxicology, and Manager of Pharmacology/Toxicology. Prior to that, Michelle worked as a Scientist in the field of toxicology at Pacific BioLabs, Inc. and as a Study Coordinator, Laboratory Technician, and Study Technician at Covance. Their experience includes serving as a Principal Investigator, Study Director, and coordinating various testing procedures in accordance with regulatory guidelines.

Michelle Eggers holds a Bachelor of Science (B.S.) degree in Animal Sciences from the University of Minnesota. Michelle later pursued a Master of Science (M.S.) degree in Biotechnology from The Johns Hopkins University. Additionally, Michelle obtained several certifications including Laboratory Animal Technologist (LATG) from AALAS in January 2013, Laboratory Animal Technician (LAT) from AALAS in September 2012, and Assistant Laboratory Animal Technician (ALAT) from AALAS in May 2012.